Related Experiment Videos
Laparoscopic splenectomy and LigaSure
Enis Yüney1, Anil Höbek, Murat Keskin
1SSK Okmeydani Training Hospital, Istanbul, Turkey.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
|August 6, 2005
Summary
Laparoscopic splenectomy (LS) using LigaSure offers precise hemostasis, simplifying the procedure for hematologic diseases like ITP. This initial series shows LS with LigaSure is safe, efficient, and has minimal complications.
Area of Science:
- Minimally Invasive Surgery
- Surgical Technology
- Hematology
Background:
- Laparoscopic splenectomy (LS) is a preferred surgical approach for hematologic conditions.
- Achieving precise hemostasis is crucial for successful LS.
- LigaSure is an energy-based device designed for effective tissue sealing.
Purpose of the Study:
- To evaluate the safety and efficacy of LigaSure for hemostasis during laparoscopic splenectomy.
- To assess the impact of LigaSure on operative time and postoperative outcomes in patients undergoing LS.
- To present initial findings on using LigaSure in a series of patients with Immune Thrombocytopenic Purpura (ITP).
Main Methods:
- Prospective case series of 10 patients undergoing LS for ITP.
- Utilized LigaSure device for achieving hemostasis during the procedure.
- Collected data on operative time, blood loss, spleen dimensions, and postoperative outcomes.
Main Results:
- All 10 patients completed LS without conversion to open surgery.
- Mean operative time was 93 minutes, with mean blood loss of 60 mL.
- No postoperative complications were reported, with an average hospital stay of 4.3 days.
Conclusions:
- Laparoscopic splenectomy using LigaSure is a safe and effective method for achieving hemostasis.
- The procedure is time-sparing and associated with minimal complications in this patient cohort.
- LigaSure facilitates easier and more precise hemostasis during LS for hematologic diseases.